Natural Product: NPC302044

Natural Product IDNPC302044
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
RALMOKVINHMHFN-OGHRFRAUSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001549] Monoterpenoids
          • [CHEMONTID:0000051] Aromatic monoterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey RALMOKVINHMHFN-OGHRFRAUSA-N
Standard InCHI InChI=1S/C38H50O6/c1-22(2)11-14-26-20-37-21-27(15-12-23(3)4)36(9,10)44-33(37)30(31(41)25-13-16-28(39)29(40)19-25)32(42)38(34(37)43,35(26,7)8)18-17-24(5)6/h11,13,16-17,19,26-27,39-40H,3,12,14-15,18,20-21H2,1-2,4-10H3/t26-,27-,37-,38-/m1/s1
SMILES CC(=CC[C@@H]1C[C@@]23C[C@@H](CCC(=C)C)C(C)(C)OC2=C(C(=O)c2ccc(c(c2)O)O)C(=O)[C@](CC=C(C)C)(C3=O)C1(C)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   602.36 Volume:   657.955
?
Van der Waals volume.
Dense:   0.916 LogP:   6.31
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.807
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.711
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   27.0
TPSA:   100.9
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.097 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   6.142 Fsp3:   0.553
MCE-18:   158.034
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.917 Fluc inhibitor:   0.058
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.032
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.466
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.515 Promiscuous compounds:   0.123

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.847 MDCK Permeability:   -4.682
Pgp-inhibitor:   0.001 Pgp-substrate:   0.0
PAMPA:   0.573
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.038 30% Bioavailability (F30%):   0.023
50% Bioavailability (F50%):   0.987

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.027 MRP1:   0.952
Plasma Protein Binding (PPB):   89.703% Volume Distribution (VD):   0.233
Fu: 11.473%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.889 BCRP inhibitor:   0.002
BSEP inhibitor:   0.118

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.288
CYP2C19-inhibitor:   0.98 CYP2C19-substrate:   0.198
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.411
CYP3A4-inhibitor:   0.967 CYP3A4-substrate:   0.752
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.999
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  7.146 Half-life (T1/2):  1.106

ADMET: Toxicity

hERG Blockers:  0.032 hERG Blockers (10um):  0.397
Human Hepatotoxicity (H-HT):  0.608 Drug-induced Liver Injury (DILI):  0.668
AMES Toxicity:  0.382 Rat Oral Acute Toxicity:  0.694
Maximum Recommended Daily Dose:  0.333 Skin Sensitization:  0.999
Carcinogencity:  0.689 Eye Corrosion:  0.0
Eye Irritation:  0.082 Respiratory Toxicity:  0.868
Drug-induced Neurotoxicity:  0.66 Ototoxicity:  0.916
Hematotoxicity:  0.328 Drug-induced Nephrotoxicity:  0.984
Genotoxicity:  0.98 RPMI-8226 Immunitoxicity:  0.024
A549 Cytotoxicity:  0.74 Hek293 Cytotoxicity:  0.254
BCF:   2.044
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.611
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   8.098
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   7.841
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6502 Moronobea coccinea Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[23245650]
NPO4624 Agathosma dielsiana Species Rutaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO2690 Carapichea ipecacuanha Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO3715 Helianthus rigidus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO6502 Moronobea coccinea Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO2690 Carapichea ipecacuanha Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2690 Carapichea ipecacuanha Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO2690 Carapichea ipecacuanha Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4624 Agathosma dielsiana Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6502 Moronobea coccinea Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3715 Helianthus rigidus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT38 Individual protein Signal transducer and activator of transcription 3 Homo sapiens Inhibition n.a. n.a. % PMID[36461923]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1229 Cell line Huh-7 Homo sapiens Activity = 11.09 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 11.75 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 4.17 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens IC50 = 9300.0 nM PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 80.82 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 80.26 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 3.01 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 5.65 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 6.37 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity n.a. n.a. n.a. PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 2.09 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 5.35 % PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 11.74 % PMID[36461923]
NPT65 Cell line HepG2 Homo sapiens IC50 = 11300.0 nM PMID[36461923]
NPT1229 Cell line Huh-7 Homo sapiens Activity = 77.7 % PMID[36461923]
NPT20904 Cell line Hep 3B2 Homo sapiens IC50 = 17100.0 nM PMID[36461923]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC302044 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC294679
1.0 High Similarity NPC145301
1.0 High Similarity NPC600911
0.8857 High Similarity NPC8493
0.8857 High Similarity NPC469375
0.8857 High Similarity NPC110855
0.8857 High Similarity NPC144247
0.8649 High Similarity NPC606227
0.8649 High Similarity NPC610595
0.8514 High Similarity NPC231479
0.7895 Intermediate Similarity NPC606237
0.75 Intermediate Similarity NPC479152
0.6951 Remote Similarity NPC305710
0.6933 Remote Similarity NPC268930
0.6875 Remote Similarity NPC264229
0.6875 Remote Similarity NPC46549
0.6875 Remote Similarity NPC606601
0.593 Remote Similarity NPC602531
0.5529 Remote Similarity NPC469857
0.5529 Remote Similarity NPC245760
0.5309 Remote Similarity NPC149773
0.5301 Remote Similarity NPC483069
0.5294 Remote Similarity NPC297797
0.5227 Remote Similarity NPC471968
0.5176 Remote Similarity NPC46242
0.5176 Remote Similarity NPC91887
0.5176 Remote Similarity NPC93556

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC302044 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data